Antibody Recognition and Neutralization Determinants on Domains I and II of West Nile Virus Envelope Protein - Wikidata - awgldk - TriplyDB

Antibody Recognition and Neutralization Determinants on Domains I and II of West Nile Virus Envelope Protein

Antibody Recognition and Neutralization Determinants on Domains I and II of West Nile Virus Envelope Protein

http://www.wikidata.org/entity/Q27477718

about

Mechanism and significance of cell type-dependent neutralization of flaviviruses Shake, rattle, and roll: Impact of the dynamics of flavivirus particles on their interactions with the host Zika Virus Infection during Pregnancy in Mice Causes Placental Damage and Fetal Demise A Mouse Model of Zika Virus Pathogenesis Monoclonal antibody-mediated enhancement of dengue virus infection in vitro and in vivo and strategies for prevention Identifying the Role of E2 Domains on Alphavirus Neutralization and Protective Immune Responses A CRISPR screen defines a signal peptide processing pathway required by flaviviruses Degrees of maturity: the complex structure and biology of flaviviruses A crucial role for infected-cell/antibody immune complexes in the enhancement of endogenous antiviral immunity by short passive immunotherapy Lethal antibody enhancement of dengue disease in mice is prevented by Fc modification Defining Limits of Treatment with Humanized Neutralizing Monoclonal Antibody for West Nile Virus Neurological Infection in a Hamster Model Induction of Epitope-Specific Neutralizing Antibodies against West Nile Virus Type- and Subcomplex-Specific Neutralizing Antibodies against Domain III of Dengue Virus Type 2 Envelope Protein Recognize Adjacent Epitopes Complement Protein C1q Inhibits Antibody-Dependent Enhancement of Flavivirus Infection in an IgG Subclass-Specific Manner Genetically delivered antibody protects against West Nile virus Maturation of West Nile Virus Modulates Sensitivity to Antibody-Mediated Neutralization Enzyme-Linked Immunosorbent Assays Using Novel Japanese Encephalitis Virus Antigen Improve the Accuracy of Clinical Diagnosis of Flavivirus Infections Humanized Monoclonal Antibodies Derived from Chimpanzee Fabs Protect against Japanese Encephalitis Virus In Vitro and In Vivo Antibodies to Envelope Glycoprotein of Dengue Virus during the Natural Course of Infection Are Predominantly Cross-Reactive and Recognize Epitopes Containing Highly Conserved Residues at the Fusion Loop of Domain II The relative contribution of antibody and CD8+ T cells to vaccine immunity against West Nile encephalitis virus Toll-Like Receptor 3 Has a Protective Role against West Nile Virus Infection West Nile virus–induced acute flaccid paralysis is prevented by monoclonal antibody treatment when administered after infection of spinal cord neurons Closing the door on flaviviruses: Entry as a target for antiviral drug design The structural immunology of antibody protection against West Nile virus The Stoichiometry of Antibody-Mediated Neutralization and Enhancement of West Nile Virus Infection Humoral Immune Responses of Dengue Fever Patients Using Epitope-Specific Serotype-2 Virus-Like Particle Antigens Crystal Structure of Dengue Virus Type 1 Envelope Protein in the Postfusion Conformation and Its Implications for Membrane Fusion Molecular mechanisms of antibody-mediated neutralisation of flavivirus infection Structural Insights into the Mechanisms of Antibody-Mediated Neutralization of Flavivirus Infection: Implications for Vaccine Development A Therapeutic Antibody against West Nile Virus Neutralizes Infection by Blocking Fusion within Endosomes Human Monoclonal Antibodies against West Nile Virus Induced by Natural Infection Neutralize at a Postattachment Step Impact of Quaternary Organization on the Antigenic Structure of the Tick-Borne Encephalitis Virus Envelope Glycoprotein E Identification of Continuous Human B-Cell Epitopes in the Envelope Glycoprotein of Dengue Virus Type 3 (DENV-3)Structural basis for the preferential recognition of immature flaviviruses by a fusion-loop antibody Complement Protein C1q Reduces the Stoichiometric Threshold for Antibody-Mediated Neutralization of West Nile Virus Dengue virus neutralization is modulated by IgG antibody subclass and Fcγ receptor subtype PCP Consensus Sequences of Flaviviruses: Correlating Variance with Vector Competence and Disease Phenotype Neutralizing and non-neutralizing monoclonal antibodies against dengue virus E protein derived from a naturally infected patient Development of a recombinant tetravalent dengue virus vaccine: Immunogenicity and efficacy studies in mice and monkeys The Development of Therapeutic Antibodies That Neutralize Homologous and Heterologous Genotypes of Dengue Virus Type 1

P2860

Q23032973-C3A0CE50-D562-4363-ABB6-B47D5E08A1A5 Q23925011-251F6A90-602C-4246-B8B6-F50EAE47B130 Q24050115-3AF23A7A-1A08-4133-AA0D-066476EF0451 Q24261408-8C873A1F-1763-4A58-8725-BD2AE5331E00 Q24684689-E74ECD02-6B56-4E1B-AF78-74B084105F1B Q24701741-30B8A53D-6DF9-4F67-BE69-CFF7560FDCE2 Q24705237-D4D3CD0E-060B-4FD2-9878-F798EC837E33 Q26824712-1A5A0422-414E-4B13-8FAD-48B76307EF4A Q27314576-3DA6D2C6-F3D4-49EC-835B-0728A546B6C5 Q27315772-470C5AB7-7445-40C1-A9EF-7883D42A8595 Q27480795-5355AA0B-2589-4447-AF8F-86D43E33C453 Q27484980-6C084F62-436C-4467-8EDA-8880D7CDFEFD Q27485031-9F20B9B5-063F-4CE5-87A3-F7AF4CBFBE3B Q27485131-C4D9B797-A9F1-4942-BAC8-13431302D9D9 Q27485481-F45E64A8-4CA5-420F-8714-7A5888F401B5 Q27485890-EA15609C-82C1-4FDF-AE87-7B005E4B2403 Q27486109-CE0BA319-859D-411E-9045-18C029277773 Q27486404-9F567680-614A-4DFE-8896-9FF141D2CE1E Q27486409-5475DA2D-6DDA-4675-8EDB-B5DBC5A5CA8D Q27486421-BED47142-2C49-4F69-B39B-E988E1E75EAD Q27487124-99F830B6-7BBA-4D02-A643-EBE1687AB278 Q27487333-56664C55-D6B9-46E0-85D3-5B22E1B7711A Q27487953-F5C2BA58-EBBD-4A7D-B736-EB29BFE9EE1E Q27487955-78EB1AB6-CE1E-439C-A200-2A3648AB8714 Q27488224-A5A45E6E-4BDC-4A47-8B90-4F6F3F920779 Q27488243-AE008A9E-0DFA-4131-AEFB-513DCD3EBF4E Q27488305-973116E9-95AB-41B6-BF6F-83FBDDDF6200 Q27488337-2E10C439-DD13-4509-9CF5-9004D5ABB3BB Q27488364-3C6E53AE-F560-4A1A-A505-A43FD8A27369 Q27488367-B8090BA2-F260-41B4-9500-13BA2D42286B Q27488791-E8C8777F-5E80-4E98-8E1C-8E7024F56EEC Q27489515-4655CB5D-9544-495E-A932-F5B99E15CBD2 Q27489953-9893CC7E-2032-45CB-8C61-43E3100CFD70 Q27490283-22C761EA-E307-463C-AD6F-DF891DA1F198 Q27490423-99BBCE68-C72E-48B5-956F-AEC09FFCCDB1 Q27490436-F27BAA90-C2E8-4795-BB87-F3570BABD62F Q27490925-BC038384-1BAA-4526-B5F0-F1B849B37AD8 Q27490987-1CE60522-8E15-49F7-8B64-8F88A6ECDCEA Q27491049-E68CDFBE-BBBC-4A47-8058-DAA0D9229F0C Q27491317-6B568016-7160-40A5-9580-EB719B063534

P2860

Antibody Recognition and Neutralization Determinants on Domains I and II of West Nile Virus Envelope Protein

http://www.wikidata.org/entity/Q27477718

description

2006 nî lūn-bûn

@nan

2006 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Antibody Recognition and Neutr ...... st Nile Virus Envelope Protein

@ast

Antibody Recognition and Neutr ...... st Nile Virus Envelope Protein

@en

Antibody Recognition and Neutr ...... st Nile Virus Envelope Protein

@nl

type

label

Antibody Recognition and Neutr ...... st Nile Virus Envelope Protein

@ast

Antibody Recognition and Neutr ...... st Nile Virus Envelope Protein

@en

Antibody Recognition and Neutr ...... st Nile Virus Envelope Protein

@nl

prefLabel

Antibody Recognition and Neutr ...... st Nile Virus Envelope Protein

@ast

Antibody Recognition and Neutr ...... st Nile Virus Envelope Protein

@en

Antibody Recognition and Neutr ...... st Nile Virus Envelope Protein

@nl

P1433

Q27477718-AF5772C5-1B8A-4DEE-858B-C417FEA003B9

P1476

Q27477718-62EFF9BF-9D0D-4D11-B53F-77A379BDF3C2

P2093

Q27477718-25060504-A393-4A8A-B73E-6FAED9BD1EB7

Q27477718-490E6567-E2A1-413A-BB9C-48735D48813A

Q27477718-5918EDD5-798C-4897-9712-649FA9370CAE

Q27477718-6E7742E6-C5C2-4187-87DE-BE3EA4641AB1

Q27477718-76B1DDC5-A8DD-467F-9522-0D09442AF5CA

Q27477718-987BF4BA-16FF-4D45-8DBE-53FD15A2F509

Q27477718-98CA3EEC-21DA-401B-A919-69443ADC7394

Q27477718-B48B5B90-E763-4F1F-82AB-FCFF84605CA5

P2860

Q27477718-01F8B4B6-C831-4A30-A7C5-5BEAAC3E9F17

Q27477718-080246EC-5C0E-47C5-AD92-A630E5A7354E

Q27477718-10AD528F-D360-4444-9609-A4AEE7DB1738

Q27477718-1A6D965A-FED6-4B2B-87C0-B625D986955A

Q27477718-1EE2FE8C-54FC-494B-ACF8-0052F2C2D71D

Q27477718-1F080ABD-7692-4DAD-9369-3E1752A444BA

Q27477718-205E04EA-E826-4CCD-AFFC-D01F991283B4

Q27477718-21C4C1C2-6F79-48C0-BA88-42DA2AAF13DA

Q27477718-291F8FD0-943D-44BF-AC0A-BC4120D2ACE9

Q27477718-2AD5FEAF-3729-47E8-BD70-A859A20E5EF7

P304

Q27477718-FAF91701-FC99-45B7-8A13-535D0CBB0FFD

P31

Q27477718-0A419977-D02A-46F3-A0B3-1DBD3F7F5B59

P3181

Q27477718-D4AA34FE-5CDB-46AE-A946-1CB4ACFACC09

P356

Q27477718-8A94B091-238B-4880-ADF0-3B0EA4D00429

P433

Q27477718-A372C9BB-0B37-422E-B9BA-68BC64D66730

P478

Q27477718-DEFBB038-5457-453C-9C0E-90410919D8AA

P50

Q27477718-5B1D6BCE-3187-4359-9709-A57FC14469B9

Q27477718-9E134B7D-764D-4FB7-BB32-11AF5E0F1791

Q27477718-E91AB2E6-451C-4C21-BD7D-B6D540F3F232

Q27477718-FB2FC33B-6F5F-41AE-9DB8-C3BD7E405037

P5008

Q27477718-165BEF6B-948D-4BB1-985C-3F15443A671F

P577

Q27477718-CEB18F78-5F25-4D25-A18D-2F4F39B7A4B5

P698

Q27477718-0F80DBC6-A652-441C-A269-520A2123B3CD

P921

Q27477718-39903E1A-DDF4-4FBC-B420-09567B392B5C

Q27477718-F11C604A-7887-419E-9C02-9FF5B6FD01D0

P932

Q27477718-C9B99CB7-C12D-430C-9565-7E51BA76F6C3

P3181

P356

P1433

Journal of Virology

P1476

Antibody Recognition and Neutr ...... st Nile Virus Envelope Protein

@en

P2093

Anantha Marri

http://www.w3.org/2001/XMLSchema#string

Bat-El Lachmi

http://www.w3.org/2001/XMLSchema#string

Christopher A Nelson

http://www.w3.org/2001/XMLSchema#string

Daved H Fremont

http://www.w3.org/2001/XMLSchema#string

Grant E Nybakken

http://www.w3.org/2001/XMLSchema#string

Michael Engle

http://www.w3.org/2001/XMLSchema#string

Qing Xu

http://www.w3.org/2001/XMLSchema#string

Udy Olshevsky

http://www.w3.org/2001/XMLSchema#string

P2860

Localization and Characterization of Flavivirus Envelope Glycoprotein Cross-Reactive Epitopes

Structure of dengue virus: implications for flavivirus organization, maturation, and fusion

New mouse model for dengue virus vaccine testing

Modulation of Dengue virus infection in human cells by alpha, beta, and gamma interferons.

Mutational Evidence for an Internal Fusion Peptide in Flavivirus Envelope Protein E

Complement activation is required for induction of a protective antibody response against West Nile virus infection

Biophysical Characterization and Vector-Specific Antagonist Activity of Domain III of the Tick-Borne Flavivirus Envelope Protein

Monoclonal Antibodies That Bind to Domain III of Dengue Virus E Glycoprotein Are the Most Efficient Blockers of Virus Adsorption to Vero Cells

Protective and therapeutic capacity of human single-chain Fv-Fc fusion proteins against West Nile virus

West Nile Virus Discriminates between DC-SIGN and DC-SIGNR for Cellular Attachment and Infection

P304

12149-59

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

2640136

http://www.w3.org/2001/XMLSchema#string

P356

10.1128/JVI.01732-06

http://www.w3.org/2001/XMLSchema#string

P433

24

http://www.w3.org/2001/XMLSchema#string

P478

80

http://www.w3.org/2001/XMLSchema#string

P50

Michael S. Diamond

Soila Sukupolvi-Petty

Theodore C Pierson

Theodore Oliphant

P5008

P577

2006-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

17035317

http://www.w3.org/2001/XMLSchema#string

P921

West Nile virus

P932

1676294

http://www.w3.org/2001/XMLSchema#string